Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis

A Kuendgen; M Lauseker; AF List; P Fenaux; AA Giagounidis; NA Brandenburg; J Backstrom; A Glasmacher; J Hasford; U Germing

doi:10.1038/leu.2012.369

Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis

A Kuendgen, M Lauseker, AF List, P Fenaux, AA Giagounidis, NA Brandenburg, J Backstrom, A Glasmacher, J Hasford, U Germing

Research output: Contribution to journal › Article › Academic › peer-review

58 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1072-1079
Number of pages	8
Journal	Leukemia
Volume	27
Issue number	5
DOIs	https://doi.org/10.1038/leu.2012.369
Publication status	Published - 2013
Externally published	Yes

Access to Document

10.1038/leu.2012.369

Cite this

Kuendgen, A., Lauseker, M., List, AF., Fenaux, P., Giagounidis, AA., Brandenburg, NA., Backstrom, J., Glasmacher, A., Hasford, J., & Germing, U. (2013). Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis. Leukemia, 27(5), 1072-1079. https://doi.org/10.1038/leu.2012.369

@article{5d1aef3e06ff466eb07fc7ee1e832ca5,

title = "Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis",

author = "A Kuendgen and M Lauseker and AF List and P Fenaux and AA Giagounidis and NA Brandenburg and J Backstrom and A Glasmacher and J Hasford and U Germing",

year = "2013",

doi = "10.1038/leu.2012.369",

language = "Undefined/Unknown",

volume = "27",

pages = "1072--1079",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "5",

}

Kuendgen, A, Lauseker, M, List, AF, Fenaux, P, Giagounidis, AA, Brandenburg, NA, Backstrom, J, Glasmacher, A, Hasford, J & Germing, U 2013, 'Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis', Leukemia, vol. 27, no. 5, pp. 1072-1079. https://doi.org/10.1038/leu.2012.369

Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis. / Kuendgen, A; Lauseker, M; List, AF; Fenaux, P; Giagounidis, AA; Brandenburg, NA; Backstrom, J; Glasmacher, A; Hasford, J; Germing, U.

In: Leukemia, Vol. 27, No. 5, 2013, p. 1072-1079.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysis

AU - Kuendgen, A

AU - Lauseker, M

AU - List, AF

AU - Fenaux, P

AU - Giagounidis, AA

AU - Brandenburg, NA

AU - Backstrom, J

AU - Glasmacher, A

AU - Hasford, J

AU - Germing, U

PY - 2013

Y1 - 2013

U2 - 10.1038/leu.2012.369

DO - 10.1038/leu.2012.369

M3 - Article

VL - 27

SP - 1072

EP - 1079

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 5

ER -